We are actively tracking the number of publications by the scientific community which reference our structures, whether in the main text, figure captions or supplementary material. Selected articles are manually reviewed. Publications by SSGCID authors are excluded from the manually reviewed list. From our manual curation results, we estimate that the false positive rate might be as high as 50% for some structures.
This list was obtained from Google Scholar searches using an API provided by Christian Kreibich.
| Structure | Year released | #citations |
|---|---|---|
| 8UR2 | 2023 | 0 |
| 8UR4 | 2024 | 0 |
| 8UR5 | 2023 | 0 |
| 8UR7 | 2023 | 0 |
| 8UZ4 | 2023 | 0 |
| 8UZ8 | 2023 | 0 |
| 8UZI | 2023 | 0 |
| 8UZK | 2023 | 0 |
| 8UZM | 2023 | 0 |
| 8UZN | 2023 | 0 |
| # | PDB | Additional SSGCID structures cited | Link | Title | Year | Citation | Highlighted abstract |
|---|---|---|---|---|---|---|---|
| 1 | 3i3r | - | http://pubs.acs.org/doi/abs/10.1021/acsinfecdis.6b00181 | Structure-Based Targeting of Orthologous Pathogen Proteins Accelerates Antiparasitic Drug Discovery | 2017 | V Jain, A Sharma, G Singh, M Yogavel - ACS Infectious , 2017 - ACS Publications | ... Structures for dihydrofolate reductase (DHFR) inhibitors pyrimethamine, methotrexate, and trimetrexate that are active against P. falciparum, T. brucei, and T. cruzi, respectively. (B) DHFR domain architectures and active site residues are similar in many pathogens: Trypanosoma cruzi (PDB: 3HBB), Cryptosporidium hominis (PDB: 1QZF), Trypanosoma brucei (PDB: 3QFX), Babesia bovis (PDB: 3I3R),. ... |
| 2 | 4lgv | - | http://pubs.acs.org/doi/abs/10.1021/acscatal.6b03440 | Substrate Channeling in an Artificial Metabolon: A Molecular Dynamics Blueprint for an Experimental Peptide Bridge | 2017 | Y Liu, DP Hickey, JY Guo, E Earl, S Abdellaoui - ACS , 2017 - ACS Publications | Figure 3. (A) Illustration of the proposed channeling complex using a poly(lysine) bridge as an electrostatic surface between hexokinase (HK; PDB 3VF6) and glucose-6-phosphate dehydrogenase (G6PDH; PDB 4LGV). |
| 3 | 5ts2 | - | http://pubs.acs.org/doi/abs/10.1021/acs.jpcb.7b09543 | Umbrella Sampling and X-ray Crystallographic Analysis Unveil an Arg-Asp Gate Facilitating Inhibitor Binding Inside Phosphopantetheine Adenylyltransferase | 2018 | A Mondal, R Chatterjee, S Datta- The Journal of Physical, 2018 - ACS Publications | In this study, we have attempted to further comprehend the structural details and mechanisms involved in AcCoA binding Material and method: MD simulations The PPATWT-AcCoA structure used for this study was obtained from RCSB- PDB ( PDB ID: 3X1J) |
| 4 | 3gka | 3r20, 4die, 3nxs, 3tk1, 4kam, 3md0 | http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00078 | Impact of Binding Site Comparisons on Medicinal Chemistry and Rational Molecular Design | 2016 | C Ehrt, T Brinkjost, O Koch - Journal of medicinal chemistry, 2016 - ACS Publications | ... of 3D structures of proteins and protein ligand complexes is one prerequisite for rational structure-based drug design that deals with the utilization of these structural data to ... Figure 1. PDB statistics on the number of released PDB entries (blue bars) and the number of new ... |
| 5 | 2lwk | - | http://pubs.acs.org/doi/abs/10.1021/acs.jcim.5b00593 | Can Holo NMR Chemical Shifts be Directly Used to Resolve RNA-Ligand Poses? | 2016 | AT Frank - Journal of Chemical Information and Modeling, 2016 - ACS Publications | ... shift data within standard procedures to aid in efficiently determining the 3D structure ofRNA-ligand complexes by acting as an additional source of structural information that is 4 Page4 of 30 ... promoter-DPQ complex (PDBID: 2LWK, BMRBID: 18633)37 (see Fig. 1). ... |
| 6 | 3d64 | 3glq, 3n58 | http://pubs.acs.org/doi/abs/10.1021/acs.jcim.5b00299 | An Inexpensive Method for Selecting Receptor Structures for Virtual Screening | 2015 | Z Huang, CF Wong - Journal of chemical information and , 2015 - ACS Publications | ... SPI also performed better than the best docking energy, the molecular volume of thebound ligand, and the resolution of crystal structure in selecting good receptorstructures for virtual screening. The implications of these findings ... |
| 7 | 3qhx | - | http://pubs.acs.org/doi/abs/10.1021/acs.jafc.7b02391 | Structural Insights into Substrate Specificity of Cystathionine -Synthase from Corynebacterium glutamicum | 2017 | HY Sagong, KJ Kim - Journal of agricultural and food chemistry, 2017 - ACS Publications | ... protein mass was 2.13 3 Da 1 with a solvent content of approximately 42.27%.(17) The structure of CgMetB was determined by molecular replacement with the CCP4 version of MOLREP,(18) with the structure of MetB from M. ulcerans ( PDB code 3QHX ) used as ... |
| 8 | 3uam | - | http://pubs.acs.org/doi/abs/10.1021/acs.chemrev.7b00421 | Oxygen Activation by Cu LPMOs in Recalcitrant Carbohydrate Polysaccharide Conversion to Monomer Sugars | 2017 | KK Meier, SM Jones, T Kaper, H Hansson- Chemical, 2017 - ACS Publications | Their activity and structural underpinnings provide insights into biological mechanisms of polysaccharide ... Table 4. AA10 LPMO Structures Available in the Protein Data Bank Burkholderia pseudomallei LPMO10A, BpAA10A 3UAM |
| 9 | 3p96 | - | http://pubs.acs.org/doi/abs/10.1021/acs.biochem.7b01082 | Regulatory Mechanism of Mycobacterium tuberculosis Phosphoserine Phosphatase SerB2 | 2017 | GA Grant- Biochemistry, 2017 - ACS Publications | figure Figure 1. Ribbon diagram of the structure of M. avium phosphoserine phosphatase (maPSP, Protein Data Bank entry 3p96 ) (right panel). The enzyme is a dimer with each subunit consisting of a catalytic domain (dark |
| 10 | 4ex4 | - | http://pubs.acs.org/doi/abs/10.1021/acs.biochem.7b00852 | Structural and Functional Characterization of Malate Synthase G from Opportunistic Pathogen Pseudomonas aeruginosa | 2017 | AC McVey, P Medarametla, X Chee, S Bartlett- Biochemistry, 2017 - ACS Publications | ... G. Inactivation of these enzymes has been reported to abolish the ability of P. aeruginosa to establish infection in a mammalian model system, yet we still lack the structural information to support drug design efforts. In this work, we describe the first X-ray crystal structure of P ... |